2023
DOI: 10.1016/j.lfs.2023.122121
|View full text |Cite
|
Sign up to set email alerts
|

The role of vasoactive intestinal peptide in pulmonary diseases

Hong-Lin Zhong,
Pei-Ze Li,
Di Li
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 139 publications
0
0
0
Order By: Relevance
“…VIP adeptly mitigates proinflammatory cytokine expression, promotes anti-inflammatory activity, and modulates immune cell processes, contributing to a balanced immune homeostasis 2,3 . Despite its safety and efficacy, the clinical development of VIP as an immunotherapeutic agent faces several challenges including possessing a very short half-life and undesirable off-target toxicity 4 . To overcome these limitations, researchers have begun engineering VIP using various approaches to improve its pharmaceutical properties while maintaining or enhancing its immunomodulatory activity 5 .…”
Section: Introductionmentioning
confidence: 99%
“…VIP adeptly mitigates proinflammatory cytokine expression, promotes anti-inflammatory activity, and modulates immune cell processes, contributing to a balanced immune homeostasis 2,3 . Despite its safety and efficacy, the clinical development of VIP as an immunotherapeutic agent faces several challenges including possessing a very short half-life and undesirable off-target toxicity 4 . To overcome these limitations, researchers have begun engineering VIP using various approaches to improve its pharmaceutical properties while maintaining or enhancing its immunomodulatory activity 5 .…”
Section: Introductionmentioning
confidence: 99%